Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bagley

Showing results (141-150 of 298) with videos related to

Pageof 30
Sort By:
Proteomics|May 1, 2010
EZYprep LC-coupled MALDI-TOF/TOF MS: an improved matrix spray application for phosphopeptide characterisationMark R Condina, Johan O R Gustafsson, Manuela Klingler-Hoffmann, et al.
Journal of Neurosurgery|November 7, 2025
Rate of biopsy prior to resection among patients with high-grade glioma: a nationwide database analysisSusanna D Howard, Tony Liu, Jesse Y Hsu, et al.
BMJ Open|November 17, 2020
Does the use of patient decision aids lead to cost savings? a systematic reviewPeter Scalia, Paul J Barr, Ciaran O'Neill, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
Hepatic regulation of cysteine utilization for taurine synthesisM H Stipanuk, P J Bagley, Y C Hou, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non-Small Cell Lung CancerStephen J Bagley, Suzanna Talento, Nandita Mitra, et al.
Bio Systems|January 1, 1989
Modeling adaptive biological systemsR J Bagley, J D Farmer, S A Kauffman, et al.
Radiology|February 1, 1997
Gliomas: correlation of magnetic susceptibility artifact with histologic gradeL J Bagley, R I Grossman, K D Judy, et al.
Immunology and Cell Biology|March 27, 2001
New approaches in the treatment of asthmaH S Ramshaw, J M Woodcock, C J Bagley, et al.
Neuro-Oncology Practice|September 16, 2024
No drug holidays in BRAF<sup>V600E</sup> glioma patients: An argument for dose reduction of targeted therapiesDanielle A Bazer, Anna Kolchinski, Nancy A O Bush, et al.
Frontiers in Oncology|October 14, 2024
The transformative potential of mRNA vaccines for glioblastoma and human cancer: technological advances and translation to clinical trialsIulia Tapescu, Peter J Madsen, Pedro R Lowenstein, et al.
Pageof 30

Showing results (141-150 of 298) with videos related to

Sort By:
Pageof 30
Proteomics|May 1, 2010
EZYprep LC-coupled MALDI-TOF/TOF MS: an improved matrix spray application for phosphopeptide characterisationMark R Condina, Johan O R Gustafsson, Manuela Klingler-Hoffmann, et al.
Journal of Neurosurgery|November 7, 2025
Rate of biopsy prior to resection among patients with high-grade glioma: a nationwide database analysisSusanna D Howard, Tony Liu, Jesse Y Hsu, et al.
BMJ Open|November 17, 2020
Does the use of patient decision aids lead to cost savings? a systematic reviewPeter Scalia, Paul J Barr, Ciaran O'Neill, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
Hepatic regulation of cysteine utilization for taurine synthesisM H Stipanuk, P J Bagley, Y C Hou, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non-Small Cell Lung CancerStephen J Bagley, Suzanna Talento, Nandita Mitra, et al.
Bio Systems|January 1, 1989
Modeling adaptive biological systemsR J Bagley, J D Farmer, S A Kauffman, et al.
Radiology|February 1, 1997
Gliomas: correlation of magnetic susceptibility artifact with histologic gradeL J Bagley, R I Grossman, K D Judy, et al.
Immunology and Cell Biology|March 27, 2001
New approaches in the treatment of asthmaH S Ramshaw, J M Woodcock, C J Bagley, et al.
Neuro-Oncology Practice|September 16, 2024
No drug holidays in BRAF<sup>V600E</sup> glioma patients: An argument for dose reduction of targeted therapiesDanielle A Bazer, Anna Kolchinski, Nancy A O Bush, et al.
Frontiers in Oncology|October 14, 2024
The transformative potential of mRNA vaccines for glioblastoma and human cancer: technological advances and translation to clinical trialsIulia Tapescu, Peter J Madsen, Pedro R Lowenstein, et al.
Pageof 30